Viewing StudyNCT03202940



Ignite Creation Date: 2024-05-06 @ 10:16 AM
Last Modification Date: 2024-10-26 @ 12:27 PM
Study NCT ID: NCT03202940
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-04-23
First Post: 2017-06-12

Brief Title: A Phase IBII Study of Alectinib Combined With Cobimetinib in Advanced ALK-Rearranged ALK NSCLC
Sponsor: Massachusetts General Hospital
Organization: Massachusetts General Hospital

Conditions & Keywords Data

Conditions:
Name
Non-small Cell Lung Cancer
Keywords:
Name View
Lung Cancer View